Security key
00166B105
ALX ONCOLOGY HOLDINGS INC - Common Stock, par value $0.001 per share (ALXO)
CUSIP: 00166B105
Q1 2025 13F Holders as of 31 Mar 2025
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 135,502,765
- Total 13F shares
- 34,764,459
- Share change
- -6,261,514
- Total reported value
- $21,657,278
- Put/Call ratio
- 109%
- Price per share
- $0.62
- Number of holders
- 83
- Value change
- -$4,297,920
- Number of buys
- 33
- Number of sells
- 38
Report period
Q1 2025
Institutions
83
Top holders
10
ALXO full security history
Newer quarter: Q2 2025
Previous quarter: Q4 2024
ALX ONCOLOGY HOLDINGS INC SEC filings
ALX ONCOLOGY HOLDINGS INC company facts
Broader feeds
Reporting periods
Holder history for CUSIP 00166B105
Recent filing periods:
Top shareholders of ALXO - ALX ONCOLOGY HOLDINGS INC - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| TANG CAPITAL PARTNERS LP |
13D/G
|
TANG CAPITAL MANAGEMENT, LLC |
6.3%
|
3,296,883
|
$1,681,410 | $0 | 31 Dec 2024 | |
| FMR LLC |
13F
13D/G
|
Company |
3.4%
from 13D/G
|
1,851,556
|
$3,092,098 | — | 31 Dec 2024 | |
| venBio Partners LLC |
13F
|
Company |
7.2%
|
9,699,925
|
$16,198,875 | — | 31 Dec 2024 | |
| Redmile Group, LLC |
13F
|
Company |
2.7%
|
3,689,611
|
$6,161,650 | — | 31 Dec 2024 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
2.4%
|
3,296,883
|
$5,505,795 | — | 31 Dec 2024 | |
| MORGAN STANLEY |
13F
|
Company |
1.8%
|
2,499,102
|
$4,173,500 | — | 31 Dec 2024 | |
| BlackRock, Inc. |
13F
|
Company |
1.8%
|
2,384,247
|
$3,981,691 | — | 31 Dec 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
1.6%
|
2,129,110
|
$3,555,614 | — | 31 Dec 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.4%
|
1,887,002
|
$3,151,294 | — | 31 Dec 2024 | |
| MPM BioImpact LLC |
13F
|
Company |
1%
|
1,391,434
|
$2,323,695 | — | 31 Dec 2024 | |
| Almitas Capital LLC |
13F
|
Company |
0.9%
|
1,222,945
|
$2,042,318 | — | 31 Dec 2024 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.82%
|
1,109,448
|
$1,851,000 | — | 31 Dec 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.76%
|
1,035,326
|
$1,728,994 | — | 31 Dec 2024 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
0.61%
|
826,582
|
$1,380,392 | — | 31 Dec 2024 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.61%
|
823,900
|
$1,375,913 | — | 31 Dec 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.55%
|
740,106
|
$1,236,239 | — | 31 Dec 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.52%
|
704,131
|
$1,175,899 | — | 31 Dec 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.5%
|
684,123
|
$1,142,485 | — | 31 Dec 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.42%
|
569,009
|
$950,245 | — | 31 Dec 2024 | |
| Privium Fund Management B.V. |
13F
|
Company |
0.38%
|
509,059
|
$850,129 | — | 31 Dec 2024 | |
| UBS Group AG |
13F
|
Company |
0.3%
|
408,056
|
$681,454 | — | 31 Dec 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.25%
|
343,066
|
$572,921 | — | 31 Dec 2024 | |
| LOS ANGELES CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.22%
|
301,419
|
$503,370 | — | 31 Dec 2024 | |
| XTX Topco Ltd |
13F
|
Company |
0.19%
|
263,856
|
$440,640 | — | 31 Dec 2024 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.19%
|
255,878
|
$427,316 | — | 31 Dec 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.17%
|
236,046
|
$394,197 | — | 31 Dec 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.16%
|
216,707
|
$361,901 | — | 31 Dec 2024 | |
| DIADEMA PARTNERS LP |
13F
|
Company |
0.15%
|
197,680
|
$330,126 | — | 31 Dec 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.12%
|
164,790
|
$275,199 | — | 31 Dec 2024 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.11%
|
151,620
|
$253,205 | — | 31 Dec 2024 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.1%
|
138,470
|
$231,245 | — | 31 Dec 2024 | |
| BANK OF NOVA SCOTIA |
13F
|
Company |
0.08%
|
105,306
|
$175,861 | — | 31 Dec 2024 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.07%
|
101,113
|
$168,859 | — | 31 Dec 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.07%
|
90,003
|
$150,305 | — | 31 Dec 2024 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.06%
|
75,000
|
$125,250 | — | 31 Dec 2024 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.05%
|
71,730
|
$119,789 | — | 31 Dec 2024 | |
| Aberdeen Group plc |
13F
|
Company |
0.05%
|
66,211
|
$110,572 | — | 31 Dec 2024 | |
| BARCLAYS PLC |
13F
|
Company |
0.05%
|
65,122
|
$108,754 | — | 31 Dec 2024 | |
| SEI INVESTMENTS CO |
13F
|
Company |
0.04%
|
60,795
|
$101,528 | — | 31 Dec 2024 | |
| Vanguard Personalized Indexing Management, LLC |
13F
|
Company |
0.03%
|
43,056
|
$71,904 | — | 31 Dec 2024 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.03%
|
42,516
|
$70,996 | — | 31 Dec 2024 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.03%
|
41,985
|
$70,114 | — | 31 Dec 2024 | |
| Nan Fung Group Holdings Ltd |
13F
|
Company |
0.03%
|
41,950
|
$70,057 | — | 31 Dec 2024 | |
| Deutsche Girozentrale DekaBank |
13F
|
Individual |
0.03%
|
41,000
|
$443,000 | — | 31 Dec 2024 | |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC |
13F
|
Company |
0.03%
|
39,131
|
$65,349 | — | 31 Dec 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.03%
|
37,095
|
$61,949 | — | 31 Dec 2024 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0.02%
|
32,021
|
$53,475 | — | 31 Dec 2024 | |
| CITIGROUP INC |
13F
|
Company |
0.02%
|
31,436
|
$52,499 | — | 31 Dec 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.02%
|
26,233
|
$43,789 | — | 31 Dec 2024 | |
| SG Americas Securities, LLC |
13F
|
Company |
0.02%
|
24,256
|
$41,000 | — | 31 Dec 2024 |
Institutional Holders of ALX ONCOLOGY HOLDINGS INC - Common Stock, par value $0.001 per share (ALXO) as of Q1 2025
As of 31 Mar 2025,
ALX ONCOLOGY HOLDINGS INC - Common Stock, par value $0.001 per share (ALXO) was held by
83 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
34,764,459 shares.
The largest 10 holders included
venBio Partners LLC, Redmile Group, LLC, TANG CAPITAL MANAGEMENT LLC, BlackRock, Inc., VANGUARD GROUP INC, BANK OF AMERICA CORP /DE/, Almitas Capital LLC, ACADIAN ASSET MANAGEMENT LLC, MILLENNIUM MANAGEMENT LLC, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
83
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2025 vs Q4 2024 Across Filers
Q4 2024 holders
85
Q1 2025 holders
83
Holder diff
-2
| Investor | Q4 2024 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q4 2024 Value $ | Q1 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.